
Belhaven Biopharma
Developer of a life-saving medication designed for the treatment of anaphylaxis. The company is developing a portfolio of dry powder nasal medicines to provide convenient, safe, and rapid treatments i...
Valuation
$0
Share Price
N/A
Total Raised
$51.2M
Last Round
N/A